A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer

Clinical trial NCT00683241 · COMPLETED

Trial details

NCT number: NCT00683241
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Peritoneal Cancer

Start date: 2007-11-01
Primary completion: 2009-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.